<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04874753</url>
  </required_header>
  <id_info>
    <org_study_id>UsakU4</org_study_id>
    <nct_id>NCT04874753</nct_id>
  </id_info>
  <brief_title>The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease</brief_title>
  <acronym>COVID19-CKD</acronym>
  <official_title>The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uşak University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uşak University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19 pandemic affected the admission of patients to the hospital especially the older&#xD;
      patients (&gt; 65 years old) because of curfews and the reluctance of patients to apply to the&#xD;
      hospitals. Chronic kidney disease is characterized with the progressive loss of kidney&#xD;
      function over the time and regular follow-up of patients for their kidney function and&#xD;
      treatment of complications is recommended in these patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The chronis kidney disease patients followed in Nephrology outpatient unit are going to be&#xD;
      enrolled in the study and their kidney functions (calculated with the mdrd formula to asses&#xD;
      the estimated glomerular filtration rate (eGFR)) will be evaluated 6 months before and after&#xD;
      the COVID-19 pandemia. And the rate of initiation of renal replacement therapies and the&#xD;
      change in proteinuria will be evaluated 6 months before and after the COVID-19 pandemic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 3, 2020</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>eGFR change</measure>
    <time_frame>6 months</time_frame>
    <description>a rise or decrease in eGFR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in proteinuria</measure>
    <time_frame>6 months</time_frame>
    <description>increase or decrease in ptoteinuria levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>initiation of renal replacement therapies</measure>
    <time_frame>6 months</time_frame>
    <description>need for hemodialysis or peritoneal dialysis</description>
  </secondary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Covid19</condition>
  <condition>Chronic Kidney Diseases</condition>
  <condition>Proteinuria</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>change in kidney function and proteinuria</intervention_name>
    <description>change in eGFR nad proteinuria in patients with chronic kidney disease</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with chronic kidney disease (eGFR&lt;60 ml/dk) between the ages 18-80 followed up in&#xD;
        nephrology outpatient clinic.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with chronic kidney disease on regular follow-up for 6 months before the&#xD;
             COVID19 pandemic.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients without chronic kidney disease&#xD;
&#xD;
          -  patients not on routine follow-up for 6 months before the COVID19 pandemic&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zelal Adıbelli</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uşak University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Usak University</name>
      <address>
        <city>Usak</city>
        <zip>64100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 2, 2021</study_first_submitted>
  <study_first_submitted_qc>May 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2021</study_first_posted>
  <last_update_submitted>May 2, 2021</last_update_submitted>
  <last_update_submitted_qc>May 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uşak University</investigator_affiliation>
    <investigator_full_name>Zelal Adibelli</investigator_full_name>
    <investigator_title>Assistant Prof. Zelal Adibelli</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Proteinuria</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

